Precision Pathways, LLC

Precision Pathways provides consulting services to assist researchers in generating high-quality bioanalytical data (genomics, proteomics, metabolomics, etc.) to facilitate accurate and incisive biological interpretation in the context of drug development and biotechnology development. Services include experimental design and protocol composition, bioanalytical method development guidance, data analysis and biological interpretation, pathway analysis (*most popular), pharmacovigilance analysis, hands-on training, scientific writing, assistance with paperwork for regulatory filings (e.g., FDA marketing authorization application, MAA), and expert witness testimony (familiar with criteria defined in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993)). We are intimately familiar with a wide range of technologies involving genetics/genomics, proteomics, glycomics, pharmacology, toxicology, systems biology, bioinformatics, statistics, and software engineering.